Literature DB >> 13658177

Mammalian cell cultures for study of influenza virus. I. Preparation of monolayer cultures with collagenase.

R W HINZ, J T SYVERTON.   

Abstract

Entities:  

Keywords:  INFLUENZA VIRUSES/culture; PROTEASES

Mesh:

Substances:

Year:  1959        PMID: 13658177     DOI: 10.3181/00379727-101-24818

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


× No keyword cloud information.
  9 in total

1.  INFLUENZA VIRUSES IN CELL CULTURES. I. PREPARATION AND USE OF FETAL PIG LUNG CELLS FOR QUANTAL ASSAY.

Authors:  F LEHMANN-GRUBE
Journal:  Arch Gesamte Virusforsch       Date:  1963-10-07

2.  Separation of human epidermal cells from fibroblasts in primary skin culture.

Authors:  B Hentzer; T Kobayasi
Journal:  Arch Dermatol Forsch       Date:  1975

3.  In vitro cultivation of cells from the chorioallantoic membrane of chick embryos.

Authors:  D Cursiefen; H Becht
Journal:  Med Microbiol Immunol       Date:  1975       Impact factor: 3.402

4.  Dissociation of single cells from lung or kidney tissue with elastase.

Authors:  H J Phillips
Journal:  In Vitro       Date:  1972 Sep-Oct

5.  Factors influencing the growth and maintenance of tubed cultures of embryonic chick cells.

Authors:  J P Thomas; H Ritter
Journal:  Appl Microbiol       Date:  1968-01

6.  Characteristics of a clone of endothelial cells derived from a line of normal adult rat lung cells.

Authors:  M S Parshley; J M Cerreta; I Mandl; J A Fierer; G M Turino
Journal:  In Vitro       Date:  1979-09

7.  Collagenase in equine cell culture preparation.

Authors:  G Lang
Journal:  J Clin Microbiol       Date:  1979-06       Impact factor: 5.948

8.  Isolation and characterization of rat primary lung cells.

Authors:  D S Bundschuh; S Uhlig; M Leist; A Sauer; A Wendel
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-10       Impact factor: 2.416

9.  MULTIPLICATION OF BRUCELLA IN CULTURED LYMPHOID AND NONLYMPHOID CELLS.

Authors:  M RICHARDSON; J N HOLT
Journal:  J Bacteriol       Date:  1964-10       Impact factor: 3.490

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.